제목 | Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity. | ||
---|---|---|---|
작성자 | 관리자 | 등록일 | 2013-09-16 |
내용
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.
■ volume(issue):page = 이펍
■ 게재지명(논문명) = Investigational new drugs.
■ 저자 = Kim SJ, Kim K, Park Y, Kim BS, Huh J, Ko YH, Park K, Suh C, Kim WS.
■ 책임저자 = 김원석